327. Idiopathic thrombosis Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 3 /  Drugs : 13 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathway : 1

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Clexane
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
   Academic Medical Center Amsterdam
      2018   Phase 3   EUCTR2012-001447-43-AT   Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
   Academic Medical Center Amsterdam
      2018   Phase 3   EUCTR2012-001447-43-AT   Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
   Research, Development & Innovation Department, UHCW NHS Trust
      2015   Phase 3   EUCTR2015-002357-35-GB   Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States